Michael Zezas: The U.S. Election, Clean Energy and Healthcare

Michael Zezas: The U.S. Election, Clean Energy and Healthcare

Investors are concerned about the potential impact of the upcoming U.S. presidential election in a number of sectors. Here’s what to watch.


----- Transcript -----

Welcome to the Thoughts on the Market. I'm Michael Zezas, Global Head of Fixed Income and Thematic Research from Morgan Stanley. Along with my colleagues, bringing you a variety of perspectives, I'll be talking about the impact of the U.S. elections on markets. It's Wednesday, December 13th at 10 a.m. in New York.


Following our publication last week of our early look for investors at the U.S. election, we've had plenty of discussion with clients trying to sort out what the event might mean for markets. Here's the three most frequently asked questions we've received and of course, our answers.


First, could the election be a catalyst to undo planned investment into the clean energy industry? This question often gets asked as, under what conditions could the Inflation Reduction Act be repealed? That Act allocated substantial sums to investment in clean energy alternatives, a boon for the industry. In our view, we don't see that act being repealed, even if Republicans who oppose the act take control of both Congress and the White House. We think there's too many negative local economic consequences to undoing that investment, to get a sufficient number of Republicans to vote for the repeal. However, clean energy investors should note that a Republican administration might be able to slow the spend of that money using the regulatory process.


Second, should healthcare investors be concerned that there's an election outcome that could substantially change the U.S. healthcare system? This was a concern in prior elections where Republicans promised to repeal the Affordable Care Act, an outcome current President Trump has recommitted to in his current campaign. Republicans couldn't make good on that promise, despite unified government control in 2017 and 2018. And here we think history would repeat itself with even a Republican majority having difficulty finding sufficient votes if it means restricting health care delivery to some of their voters. That said, investors in sectors that would be negatively impacted by a repeal of the Affordable Care Act could see market effects if Republicans start surging in the polls, as markets would then have to account for the possibility, albeit modest, of repeal.


Finally, when might political campaigns begin impacting markets? We don't have a clear answer here. In 2016 and 2020, health care stocks started reflecting campaign statements early in the year. Whereas macro market effects, such as the sensitivity of the Mexican peso to then candidate Trump's comments around renegotiating trade agreements, didn't kick in until much closer to November. The bottom line is that we don't really know, which is why we're here to help you prepare now.


Thanks for listening. If you enjoy the show, please share Thoughts on the Market with a friend or colleague, or leave us a review on Apple Podcasts. It helps more people find the show.

Avsnitt(1515)

Mike Wilson: Getting Ahead of 2021 Leadership Shifts

Mike Wilson: Getting Ahead of 2021 Leadership Shifts

Small caps and cyclicals outperformed significantly this year, particularly after announcement of a vaccine. Which factors could see momentum in 2021?

14 Dec 20203min

Special Episode: As a Vaccine Rolls-Out, What’s Next?

Special Episode: As a Vaccine Rolls-Out, What’s Next?

Although the first COVID-19 vaccine has now begun distribution in the U.S., the country still faces alarming numbers of new cases. We dive into the logistics of mass vaccination.

14 Dec 20207min

Andrew Sheets: Why Rates Will Rise Next Year, and Why the Fed Will Let Them

Andrew Sheets: Why Rates Will Rise Next Year, and Why the Fed Will Let Them

Many are skeptical of substantial rise in long term interest rates in the coming year, but we think market pressures will push them up more than the consensus and that the Fed will not get in the way. Chief Cross-Asset Strategist Andrew Sheets explains.

10 Dec 20202min

Michael Zezas: Can Congress Break the Stimulus Logjam?

Michael Zezas: Can Congress Break the Stimulus Logjam?

Congress is making progress on a COVID fiscal relief package, but previous efforts to strike a deal haven’t borne fruit. Why this time may be different.

9 Dec 20202min

Mike Wilson: Closing the Books on 2020

Mike Wilson: Closing the Books on 2020

Despite a year of high uncertainty, 2020 may end as a strong year for nearly every asset class—which means it may be time to step back and take a breath.

7 Dec 20203min

Andrew Sheets: Corporate Credit’s Surprising Resiliency

Andrew Sheets: Corporate Credit’s Surprising Resiliency

Corporate credit defaults have been relatively low considering the outsized shock of COVID-19. Do muted default rates also mean a muted recovery?

4 Dec 20203min

Michael Zezas: What Happens Next on U.S.-China Trade?

Michael Zezas: What Happens Next on U.S.-China Trade?

Will a Biden administration mean a reduction of trade barriers between the U.S. and China. The answer for investors: like most questions on trade, it’s a bit nuanced.

2 Dec 20203min

China 2021: The Consumer Roars Back

China 2021: The Consumer Roars Back

China’s consumers could emerge as a key GDP growth driver in 2021, fueled by COVID-19 vaccine availability, a recovery in the job market and pent-up savings by households.

1 Dec 202011min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
rss-svart-marknad
uppgang-och-fall
lastbilspodden
affarsvarlden
fill-or-kill
avanzapodden
24fragor
kapitalet-en-podd-om-ekonomi
rss-kort-lang-analyspodden-fran-di
rss-inga-dumma-fragor-om-pengar
borsmorgon
rss-dagen-med-di
bathina-en-podcast
rss-en-rik-historia
montrosepodden